FBN3

Gene Information
 
Gene Symbol
FBN3
 
Aliases
-
 
Entrez Gene ID
 
Gene Name
Fibrillin 3
 
Chromosomal Location
19p13.2
 
HGNC ID
 
Summary
This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]
  e!Ensembl
Gene
Transcript  
Protein

SNPs

SNP Id
Upstream Sequence
SNP
Downstream Sequence Functional Significance References
D19S884
20200332

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0031012 Cellular component Extracellular matrix IBA 21873635
GO:0005201 Molecular function Extracellular matrix structural constituent IBA 21873635
Protein Information
 
Protein Name
Fibrillin-3
 
Function
[Fibrillin-3]: Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-containing microfibrils provide long-term force bearing structural support.
 
UniProt
 
Pfam
Pfam Accession Pfam ID
PF12662 cEGF
PF07645 EGF_CA
PF12661 hEGF
PF00683 TB
Pathways
 
Reactome
 

 

Degradation of the extracellular matrix
Elastic fibre formation
Molecules associated with elastic fibres

Interactions
 
STRING MINT IntAct
ENSP00000341785 Q96A54 Q96A54
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Arthrogryposis
Marfan Syndrome
Endocrine System Diseases
PCOS
Musculoskeletal Diseases
Scoliosis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
 
 
 
NIH criteria 
Related 
173 PCOS patients and 194 controls 
The study concludes that FBN3 appears to have little involvement in PCOS but cannot rule out that other markers in the region of chromosome 19p13.2 are associated with PCOS or that FBN3 expression occurs in other organs and that this may be influencing the PCOS phenotype. 
FBN1, FBN2, LTBP-1, LTBP-2, D19S884 
 
 
NIH criteria 
Related 
367 (173 PCOS, 194 controls) 
FBN3 may or may not play a minor role in PCOS pathogenesis 
 
 
variants in the D19S884  
Rotterdam criteria 
Direct 
272 PCOS women and 271 controls 
Association of the D19S884 marker with PCOS identified that A8 may increase susceptibility to PCOS 
 
 
 
Rotterdam criteria 
Direct 
21 controls and 9 patients with PCOS  
Loss of fibrillin-3 during folliculogenesis may be an important factor in PCOS pathogenesis 
 
 
varient in gene 
PCOS was diagnosed by a history of six or fewer menses per year and elevated levels of total testosterone or non-SHBG-bound testosterone (uT) 
Direct 
601 women with PCOS and 168 brothers of affected women 
These findings strongly suggest that A8 of D19S884 is the chromosome 19p13.2 PCOS susceptibility locus. The association of D19S884 with markers of insulin resistance and pancreatic beta-cell dysfunction suggests that the same variant contributes to the reproductive and metabolic abnormalities of PCOS in affected women and their brothers. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412